Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
This study is ongoing, but not recruiting participants.
Sponsor:
Eisai Inc.
Information provided by (Responsible Party):
Eisai Inc.
ClinicalTrials.gov Identifier:
NCT00942968
First received: July 16, 2009
Last updated: April 10, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |